NOMOCAN PHARMACEUTICALS LLC

NEW YORK, NEW YORK 100656275

$1.35M
Total Contract Value
7 awards
First Award
Feb 27, 2023
Last Award
Sep 30, 2025
Business Size
small
CAGE Code
7ER28

Top Industries (NAICS)

NAICS CodeObligationsAwards
541715$854K5

Contract Awards

3 awards found

75N91025C00050
Department of Health and Human Services
$499K
Sep 15, 2025

PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTRIPTION.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2025
75N91023C00015
Department of Health and Human Services
$55K
Jul 13, 2023

PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE I-CORP OPTION

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75N91023C00015
Department of Health and Human Services
$300K
Feb 27, 2023

PC HAS ONE OF THE LOWEST 5-YEAR SURVIVAL RATES AMONG ALL CANCER TYPES, REMAINING BELOW 10% FOR THE PAST 40 YEARS, INDICATING A NEED FOR EFFECTIVE PC THERAPIES. STUDIES HAVE SHOWN THAT NMC-521 BINDS SELECTIVELY TO SEVERAL PC CELL LINES WITH MARKED ANT

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023

Business Details

UEI
H9T8M7ZBYAR8
CAGE Code
7ER28
Address
310 E 67TH ST STE 1-45
NEW YORK, NY 100656275
Congressional District
NY-12

Parent Company

NOMOCAN PHARMACEUTICALS LLC

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov